Article Category:
Case Report

Case Report: Local Treatment of a Leishmania tropica Infection in a Syrian Child with a Novel Filmogenic Preparation of Pharmaceutical Sodium Chlorite (LeiProtect®)

Dirk Debus Department of Dermatology, Paracelsus Medizinische Privatuniversität, Klinikum Nürnberg, Prof.-Ernst-Nathan-Straße 1, Germany;

Search for other papers by Dirk Debus in
Current site
Google Scholar
PubMed Close
,
Semra Genç Institute for Inorganic and Analytical Chemistry and Freiburg Material Research Center (FMF), Albert-Ludwigs-University Freiburg, Albertstraße 21, Freiburg, Germany;

Search for other papers by Semra Genç in
Current site
Google Scholar
PubMed Close
,
Philipp Kurz Institute for Inorganic and Analytical Chemistry and Freiburg Material Research Center (FMF), Albert-Ludwigs-University Freiburg, Albertstraße 21, Freiburg, Germany;

Search for other papers by Philipp Kurz in
Current site
Google Scholar
PubMed Close
,
Martin Holzer Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology and Biopharmacy, Albert-Ludwigs-Universität, Hermann-Herder-Straße 9, Freiburg, Germany;

Search for other papers by Martin Holzer in
Current site
Google Scholar
PubMed Close
,
Kurt Bauer Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology and Biopharmacy, Albert-Ludwigs-Universität, Hermann-Herder-Straße 9, Freiburg, Germany;

Search for other papers by Kurt Bauer in
Current site
Google Scholar
PubMed Close
,
Ralph Heimke-Brinck Pharmacy Department, Universitätsklinikum Erlangen, Palmsanlage 3, Erlangen, Germany;

Search for other papers by Ralph Heimke-Brinck in
Current site
Google Scholar
PubMed Close
,
Martin Baier Pharmacy Department, Universitätsklinikum Erlangen, Palmsanlage 3, Erlangen, Germany;

Search for other papers by Martin Baier in
Current site
Google Scholar
PubMed Close
,
Heidi Sebald Mikrobiologisches Institut – Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Wasserturmstraße 3/5, Erlangen, Germany;

Search for other papers by Heidi Sebald in
Current site
Google Scholar
PubMed Close
,
Andrea Debus Mikrobiologisches Institut – Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Wasserturmstraße 3/5, Erlangen, Germany;

Search for other papers by Andrea Debus in
Current site
Google Scholar
PubMed Close
,
Christian Bogdan Mikrobiologisches Institut – Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Wasserturmstraße 3/5, Erlangen, Germany;
Medical Immunology Campus Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Schlossplatz 1, Erlangen, Germany;

Search for other papers by Christian Bogdan in
Current site
Google Scholar
PubMed Close
, and
Kurt-Wilhelm Stahl Waisenmedizin e. V. Promoting Access to Care with Essential Medicine (PACEM), Non-Profit Non-Governmental Organization, Günterstalstraße 60, Freiburg, Germany

Search for other papers by Kurt-Wilhelm Stahl in
Current site
Google Scholar
PubMed Close
DOI:
https://doi.org/10.4269/ajtmh.21-0962
Volume/Issue:
Volume 106: Issue 3
Page(s):
857–860
Restricted access
Get Permissions

ABSTRACT.

Cutaneous leishmaniasis (CL) frequently entails chronic skin lesions that heal only slowly. Until now, the available therapeutic options are very limited. Here, we present a case of a 5½-year-old Syrian refugee with two progressive lower-leg skin ulcers caused by Leishmania tropica. The patient received topical treatment with LeiProtect®, a newly developed, hydroxypropylcellulose-based, filmogenic gel containing nontoxic concentrations of pharmaceutical sodium chlorite. The skin lesions completely healed within 8 weeks and did not relapse during 1 year of follow-up, underlining the efficacy of this novel local therapy of CL.

Author Notes

Address correspondence to Christian Bogdan, Mikrobiologisches Institut – Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Wasserturmstraße 3/5, D-91054 Erlangen, Germany, E-mail: christian.bogdan@uk-erlangen.de or Kurt-Wilhelm Stahl, Waisenmedizin e. V. Promoting Access to Care with Essential Medicine (PACEM), Non-Profit Non-Governmental Organization, Günterstalstraße 60, D-79100 Freiburg, Germany, E-mail: stahlkw@waisenmedizin.org.

These authors contributed equally to this work.

Disclosure: The patients’ parents have given their written consent to the LeiProtect treatment and to the anonymous publication of the treatment results.

Authors’ addresses: Dirk Debus, Department of Dermatology, Paracelsus Medizinische Privatuniversität, Klinikum Nürnberg, Prof.-Ernst-Nathan-Straße 1, Nürnberg, Germany, E-mail: dirk.debus@klinikum-nuernberg.de. Semra Genç and Philipp Kurz, Institute for Inorganic and Analytical Chemistry and Freiburg Material Research Center (FMF), Albert-Ludwigs-University Freiburg, Albertstraße 21, Freiburg, Germany, E-mails: semra.genc@ac.uni-freiburg.de and philipp.kurz@ac.uni-freiburg.de. Martin Holzer and Kurt Bauer, Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology and Biopharmacy, Albert-Ludwigs-Universität, Hermann-Herder-Straße 9, Freiburg, Germany, E-mails: martin.holzer@pharmazie.uni-freiburg.de and bauer.kurt.freiburg@t-online.de. Ralph Heimke-Brinck and Martin Baier, Pharmacy Department, Universitätsklinikum Erlangen, Palmsanlage 3, Erlangen, Germany, E-mails: ralph.heimke-brinck@uk-erlangen.de and martin.baier@uk-erlangen.de. Heidi Sebald and Andrea Debus, Mikrobiologisches Institut – Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Wasserturmstraße 3/5, Erlangen, Germany, E-mails: heidi.sebald@uk-erlangen.de and andrea.debus@uk-erlangen.de. Christian Bogdan, Mikrobiologisches Institut – Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Wasserturmstraße 3/5, Erlangen, Germany, and Medical Immunology Campus Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Schlossplatz 1, Erlangen, Germany, E-mail: christian.bogdan@uk-erlangen.de. Kurt-Wilhelm Stahl, Waisenmedizin e. V. Promoting Access to Care with Essential Medicine (PACEM), Non-Profit Non-Governmental Organization, Günterstalstraße 60, Freiburg, Germany, E-mail: stahlkw@waisenmedizin.org.

Copyright:
© The American Society of Tropical Medicine and Hygiene 2022
Received:
07 Sep 2021
|
Accepted:
05 Oct 2021
|
Published Online:
10 Jan 2022
Cover The American Journal of Tropical Medicine and Hygiene
The American Journal of Tropical Medicine and Hygiene
Print ISSN:
0002-9637
Online ISSN:
1476-1645
  • 1.

    Saroufim M, Charafeddine K, Issa G, Khalifeh H, Habib RH, Berry A, Ghosn N, Rady A, Khalifeh I , 2014. Ongoing epidemic of cutaneous leishmaniasis among Syrian refugees, Lebanon. Emerg Infect Dis 20: 1712–1715.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Hayani K, Dandashli A, Weisshaar E , 2015. Cutaneous leishmaniasis in Syria: clinical features, current status and the effects of war. Acta Derm Venereol 95: 62–66.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    World Health Organization , 2014. Manual for case management of cutaneous leishmaniasis in the WHO Eastern Mediterranean Region. WHO Reg Publ East Mediterr Ser 35: 1–49.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Reithinger R, Mohsen M, Wahid M, Bismullah M, Quinnell RJ, Davies CR, Kolaczinski J, David JR , 2005. Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial. Clin Infect Dis 40: 1148–1155.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Solomon M, Schwartz E, Pavlotsky F, Sakka N, Barzilai A, Greenberger S , 2014. Leishmania tropica in children: a retrospective study. J Am Acad Dermatol 71: 271–277.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Keynan Y, Larios OE, Wiseman MC, Plourde M, Ouellette M, Rubinstein E , 2008. Use of oral miltefosine for cutaneous leishmaniasis in Canadian soldiers returning from Afghanistan. Can J Infect Dis Med Microbiol 19: 394–396.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Asilian A, Sadeghinia A, Faghihi G, Momeni A , 2004. Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis. Int J Dermatol 43: 281–283.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Slape DR, Kim EN, Weller P, Gupta M , 2019. Leishmania tropica successfully treated with photodynamic therapy. Australas J Dermatol 60: e64–e65.

  • 9.

    Morizot G et al.2013. Travelers with cutaneous leishmaniasis cured without systemic therapy. Clin Infect Dis 57: 370–380.

  • 10.

    Stahl HC, Ahmadi F, Schleicher U, Sauerborn R, Bermejo JL, Amirih ML, Sakhayee I, Bogdan C, Stahl KW , 2014. A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan. BMC Infect Dis 14: 619.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11.

    Kirchberger MC, Schliep S, Bogdan C , 2019. Rhinophyma-like cutaneous leishmaniasis due to Leishmania aethiopica treated successfully with liposomal amphotericin B. Am J Trop Med Hyg 100: 231–232.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12.

    Jebran AF, Schleicher U, Steiner R, Wentker P, Mahfuz F, Stahl HC, Amin FM, Bogdan C, Stahl KW , 2014. Rapid healing of cutaneous leishmaniasis by high-frequency electrocauterization and hydrogel wound care with or without DAC N-055: a randomized controlled phase IIa trial in Kabul. PLoS Negl Trop Dis 8: e2694.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13.

    Hinz J, Hautzinger H, Stahl KW , 1986. Rationale for and results from a randomised, double-blind trial of tetrachlorodecaoxygen anion complex in wound healing. Lancet 1: 825–828.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14.

    Tissot M, Roch-Arveiller M, Mathieu J, Giroud JP, Stahl KW , 1990. Anti-inflammatory properties of a novel wound healing and immunomodulating agent, tetrachlorodecaoxygen complex (TCDO). Agents Actions 31: 368–374.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15.

    Naviaux RK , 2012. Oxidative shielding or oxidative stress? J Pharmacol Exp Ther 342: 608–618.

Past two years Past Year Past 30 Days
Abstract Views 18085 625 78
Full Text Views 199 107 0
PDF Downloads 77 11 0
 
 
 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save